Hematology
Venetoclax
BPT-1204 · Tablet
What is it used for?
Blocks BCL-2, a protein that helps cancer cells survive. Used for chronic lymphocytic leukemia / small lymphocytic lymphoma, and with specified medicines for newly diagnosed acute myeloid leukemia in older adults or those unsuitable for intensive chemotherapy. A BCL2 mutation is not required by these indications.
- Dosage form
- Tablet
- Listed strengths
- 10 mg & 100 mg
- Listed pack size
- 49's & 60's
- Mechanism
- BCL-2 inhibitor
Specifications supplied in the Everest product list; formulation, pack configuration, availability and local authorization require confirmation. These medicines are not for self-medication.
Clinical use overview
- Chronic lymphocytic leukemia / small lymphocytic lymphoma
- Selected acute myeloid leukemia combination treatments
Important information
Educational information about the active ingredient, not a treatment recommendation or a claim that Beptide's presentation is approved. Approved uses differ by country and product. Cancer medicines require specialist assessment; biomarkers, stage, previous treatments and combinations can determine eligibility.
FDA prescribing information